Valneva SE (VALN) Other Non Operating Income (2021 - 2026)
Valneva SE's (VALN) quarterly Other Non Operating Income came in at -$3.5 million in Q1 2026, down 190.62% year-on-year from $3.9 million in Q1 2025, and down 233.91% quarter-over-quarter from -$1.0 million in Q4 2025.
Valneva SE (VALN) Other Non Operating Income (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$3.5 million for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$3.5 million, down 190.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.4 million (down 264.67% YoY), and the FY2025 annual result was -$8.4 million, down 345.1% from the prior year.
- Other Non Operating Income came in at -$3.5 million for Q1 2026 at Valneva SE, down from -$1.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $14.2 million in Q4 2022 to a low of -$16.5 million in Q3 2025.
- The 5-year median for Other Non Operating Income is -$1.0 million (2025), against an average of -$970862.6.
- Peak annual rise in Other Non Operating Income reached 402.71% in 2025, while the deepest fall reached 1012.12% in 2025.
- Valneva SE's Other Non Operating Income stood at $14.2 million in 2022, then tumbled by 46.8% to $7.5 million in 2023, then dropped by 12.22% to $6.6 million in 2024, then plunged by 115.81% to -$1.0 million in 2025, then sank by 233.91% to -$3.5 million in 2026.
- The last three Other Non Operating Income figures came in at -$3.5 million (Q1 2026), -$1.0 million (Q4 2025), and -$16.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.50 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | -16.46 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 3.86 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Sep 30, 2024 | -1.48 Mn |
| Jun 30, 2024 | 926,123.32 |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 14.19 Mn |
| Sep 30, 2022 | -15.97 Mn |
| Jun 30, 2022 | -8.80 Mn |
| Mar 31, 2022 | -2.71 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | -4.01 Mn |